Latest Public Service Radio Minute
Loss of EmploymentLoss of Employment, MP3, 1.3MB
Listen to or download all our PSAsSupport Our Work
Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!
More InfoLatest News Around the Web
Psychiatrists Play Important Role In Care Of Transgender Individuals With Mental Illness, Substance Use Disorders, Expert Says
Healio (9/11, Gramigna) reported “psychiatrists play an important role in the care of transgender individuals with mental illness and substance use disorders, according to a” presentation given by Dan Karasic, MD, clinical professor of psychiatry at University of California-San Francisco at the Psych Congress 2020 Virtual Experience conference. In the presentation, Dr. Karasic also “provided an overview of the importance of updated standards set to be released in the coming World Professional Association for Transgender Health…Standards of Care Version 8.”
Related Links:
— “Transgender individuals with mental illness benefit from modernized psychiatric care “Joe Gramigna, Healio, September 11, 2020
People Who Rely On USPS For Prescription Drugs May Have Experienced “Significant” Delays In Deliveries, Report Says
The Washington Post (9/9, Romm) reports people who rely on USPS for prescription drugs “may have experienced ‘significant’ delays in their deliveries, according to a” report from Sens. Elizabeth Warren (D-MA) and Robert P. Casey Jr. (D-PA). The report accused Postmaster General Louis DeJoy of placing the “health of millions of Americans” at risk.
USA Today (9/9, Wu) reports Warren and Casey “said some of the nation’s largest pharmacies told them they were experiencing, on average, delivery delays of 18-32%, meaning deliveries that would normally take 1-2 days would instead take 3-4 days.” The senators also said the delays could pose “serious health risks to millions of Americans and (increase) costs for consumers and taxpayers.”
The AP (9/9, Daly, Izaguirre) says the report conflicts with claims made by DeJoy that the changes he implemented “should not have impacted anybody.”
CNN (9/9, Holmes, Cole) and The Hill (9/9, Wise) also cover the story.
Related Links:
— “Patients may have seen ‘significant’ delays in medicine deliveries by USPS, Senate report finds “Tony Romm, The Washington Post, September 9, 2020
Growing Number Of Americans Having Serious Reactions After Taking Unapproved Anxiety Treatment Sold In Some Dietary Supplements, Research Suggests
HealthDay (9/9, Norton) reports, “A growing number of Americans may be having serious reactions after taking phenibut – an unapproved anxiety” treatment “sold in some dietary supplements,” investigators concluded in a study that examined “calls to U.S. poison control centers.” Starting in 2015, investigators found “a sharp rise” in such calls, “going from a handful of calls each year to between 300 and 400 in 2018 and 2019.” What’s more, “the effects were sometimes life-threatening or fatal, said” one of the researchers. The findings were published online Sept. 4 in the CDC’s Morbidity and Mortality Weekly Report.
Related Links:
— “Dangerous Abuse of Anxiety Drug Phenibut Is on the Rise “Amy Norton, HealthDay, September 9, 2020
Diagnoses of AD/HD more common in Black people than for people of other races/ethnicities, meta-analysis reveals
MedPage Today (9/9, Hlavinka) reports that diagnoses of attention-deficit/hyperactivity disorder (AD/HD) “were more common in Black people than for people of other races/ethnicities,” investigators concluded in a meta-analysis that revealed “in 21 U.S. studies conducted from 1979-2020, the pooled prevalence of” AD/HD “was 14.54% for Black adults and children and 13.87% for Black children only.” In comparison, “estimates for” AD/HD “prevalence in all races/ethnicities hover around 10% in children and are lower in adults.” The findings were published online Sept. 9 in JAMA Psychiatry.
Related Links:
— MedPage Today (requires login and subscription)
APA Creates Web Site To Guide Users On What To Consider When Evaluating Mental Health Apps
Psychiatric News (9/8) reports that with the increasing “number of mental health apps available for download…psychiatrists are likely to receive questions from patients on the risks and benefits of these products.” Now, “to help psychiatrists and other mental health professionals when selecting apps,” the American Psychiatric Association “has created the APA App Advisor,” which is “a website that guides users through questions to consider when evaluating mental health apps.”
Related Links:
— “Considering Mental Health Apps? APA App Advisor Can Help, Psychiatric News , September 8, 2020
Foundation News
Nothing Found
It seems we can’t find what you’re looking for. Perhaps searching can help.